1. Home
  2. Analysis

Drowsiness and drugs of ingredients of betaxolol hydrochloride - a phase IV clinical study of FDA data


Summary:

Drowsiness is found among people who take drugs with ingredients of betaxolol hydrochloride, especially for people who are female, 60+ old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 3,667 people who have side effects when taking drugs with ingredients of betaxolol hydrochloride from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Betaxolol, Betaxolol hydrochloride, Betoptic, Betoptic s, Kerlone.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 30, 2023

3,667 people reported to have side effects when taking drugs with ingredients of betaxolol hydrochloride.
Among them, 50 people (1.36%) have Drowsiness

What is Drowsiness?

Drowsiness is found to be associated with 4,281 drugs and 4,571 conditions by eHealthMe.

Number of reports submitted per year:

Could drugs with ingredients of betaxolol hydrochloride cause Drowsiness?

Time on drugs with ingredients of betaxolol hydrochloride when people have Drowsiness *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Drowsiness when taking drugs with ingredients of betaxolol hydrochloride *:

  • female: 52.08 %
  • male: 47.92 %

Age of people who have Drowsiness when taking drugs with ingredients of betaxolol hydrochloride *:

  • 0-1: 8.89 %
  • 2-9: 6.67 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 2.22 %
  • 40-49: 11.11 %
  • 50-59: 20.0 %
  • 60+: 51.11 %

Conditions people have *:

  1. High Blood Pressure: 18 people, 36.00%
  2. Diabetes: 9 people, 18.00%
  3. Pain: 9 people, 18.00%
  4. Metastases To Bone (cancer spreads to bone): 6 people, 12.00%
  5. Breast Cancer: 6 people, 12.00%
  6. High Blood Cholesterol: 6 people, 12.00%
  7. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 6.00%
  8. Constipation: 2 people, 4.00%
  9. Lung Cancer Metastatic (lung cancer spreads to other parts): 2 people, 4.00%
  10. Stable Angina (a constant chest pain): 2 people, 4.00%

Other drugs people take *:

  1. Xalatan: 15 people, 30.00%
  2. Accupril: 13 people, 26.00%
  3. Vioxx: 13 people, 26.00%
  4. Aspirin: 9 people, 18.00%
  5. Neurontin: 8 people, 16.00%
  6. Cardura: 8 people, 16.00%
  7. Lumigan: 8 people, 16.00%
  8. Daypro: 7 people, 14.00%
  9. Femara: 7 people, 14.00%
  10. Famvir: 7 people, 14.00%

Other side effects people have besides Drowsiness *:

  1. Weakness: 19 people, 38.00%
  2. Fatigue (feeling of tiredness): 19 people, 38.00%
  3. Dizziness: 18 people, 36.00%
  4. Breathing Difficulty: 17 people, 34.00%
  5. Bradycardia (abnormally slow heart action): 15 people, 30.00%
  6. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 13 people, 26.00%
  7. Cellulitis (infection under the skin): 13 people, 26.00%
  8. Hyperlipidaemia (presence of excess lipids in the blood): 12 people, 24.00%
  9. Chest Pain: 12 people, 24.00%
  10. Pain: 11 people, 22.00%

* Approximation only. Some reports may have incomplete information.

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drugs with ingredients of betaxolol hydrochloride, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on betaxolol hydrochloride. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.